Compare ImmunityBio Inc. Common Stock (IBRX) vs iShares International Treasury Bond ETF (IGOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs iShares International Treasury Bond ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while iShares International Treasury Bond ETF trades at $39.75 (market cap $1.31B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 7.9× iShares International Treasury Bond ETF's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, iShares International Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and iShares International Treasury Bond ETF for 92 Days on average.
| IBRX | IGOV | |
|---|---|---|
Market Cap | $10.33B | $1.31B |
Volume | 11,745,198 | 493,216 |
Sector | Health | Fixed Income |
52-Week High | $11.55 | $42.99 |
52-Week Low | $1.98 | $39.65 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $10.79B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IGOV is trading at $39.70, down 0.48% on the day, with technical indicators showing a bearish trend as moving averages signal selling pressure. The stock lacks available fundamental data for key valuation and profitability metrics, creating uncertainty around its financial health. Recent market news highlights rising global bond yields, which could impact interest-rate sensitive sectors.
The outlook remains cautious due to the bearish technical setup and absence of fundamental clarity. Investment opportunities depend on forthcoming financial disclosures, while risks include market volatility from rising yields and the stock's technical weakness. Investors require updated earnings reports to assess true valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About iShares International Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities included in the underlying index. The underlying index measures the performance of fixed-rate, local currency, investment-grade, sovereign bonds from certain developed markets. The fund is non-diversified.
Read more on IGOV →
